Open AccessInteraction Between Everolimus and Tacrolimus in Renal Transplant Recipients: A Pharmacokinetic Controlled Trial
Author(s) -
Julio Pascual,
Domingo del Castillo,
Mercedes Cabello,
L. Pallardó,
Josep M. Grinyó,
Armida Fernandez,
Mercè Brunet
Publication year - 2010
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0b013e3181ccd7f2
Subject(s) - cmin , medicine , pharmacokinetics , urology , tacrolimus , everolimus , bioavailability , regimen , renal function , transplantation , dose , pharmacology , area under the curve , gastroenterology , cmax
Clinical data are lacking concerning therapeutic action and systemic exposure of tacrolimus (TAC) and everolimus (EVL) in a combined regimen in renal transplantation.